arrow
K

Kadriye Bır Yucel

etlik city hospital
H指数:8
被引数:150

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline 25-Hydroxyvitamin D and Progression-Free Survival in de novo mHSPC: Prognostic Model Development and External Validation

基线25-羟基维生素D与去势抵抗性前列腺癌中mHSPC患者的无进展生存期:预后模型构建与外部验证

2026-10-060
OAAI
Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

残余胆固醇炎症指数预测乳腺癌新辅助治疗病理完全缓解:一项多中心外部验证研究

Breast
IF7.9
2026-09-220
OA
Wearable-derived postdischarge mobility as a digital biomarker for 90-day readmission and mortality in metastatic cancer

基于可穿戴设备的出院后活动能力作为转移性癌症患者90天再入院和死亡率的数字生物标志物

2026-09-110
PRE
Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial)

肢体加压疗法与妇科癌症患者化疗诱导的周围神经病变:一项前瞻性自身对照研究(NEURO-GLOVE试验)

2026-06-180
OAAI
Immunomodulatory Effect of First-Line Cisplatin Versus Carboplatin in Response to Second-Line Nivolumab Therapy in Metastatic Non-Small Cell Lung Cancer

一线顺铂与卡铂的免疫调节效应对接受二线纳武利尤单抗治疗转移性非小细胞肺癌的响应

2025-12-010
PRE
Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)

使用炎症、营养和肌肉减少症相关标志物预测局部晚期直肠癌的病理反应:一项基于回归和人工智能的分析(CINR-AI研究)

2025-10-160
PRE
Efficacy and safety of omitting 5-fluorouracil bolus in combination chemotherapy regimens for gastrointestinal cancers: a systematic review and meta-analysis

省略5-氟尿嘧啶推注在胃肠道癌症联合化疗方案中的有效性与安全性:一项系统评价和Meta分析

2025-07-020
PRE
Prospective observational study to assess the prophylactic effect of topical diclofenac in preventing the development of hand foot syndrome in patients with colorectal and gastric cancer on capecitabine therapy

前瞻性观察性研究,旨在评估外用双氯芬酸在预防接受卡培他滨治疗的大肠癌和胃癌患者发生手足综合征方面的预防效果。

2024-09-010
PRE
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors
2022-10-0311
OAAI